Fingolimod/natalizumabTumefactive multiple sclerosis relapse after natalizumab withdrawal: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2013年 / 1433卷 / 1期
关键词：
D O I：
10.1007/s40278-013-0380-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：22 / 22
相关论文
共 50 条
  • [21] Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis
    Fragoso, Yara Dadalti
    Adoni, Tarso
    Alves-Leon, Soniza Vieira
    Apostolos-Pereira, Samira Luisa
    de Araujo, Yuna Ribeiro
    Becker, Jefferson
    Bidin Brooks, Joseph Bruno
    Correa, Eber Castro
    Damasceno, Alfredo
    de Albuquerque Damasceno, Carlos Augusto
    Ferreira, Maria Lucia B.
    da Gama, Paulo Diniz
    Diniz da Gama, Rodrigo Assad
    Gomes, Sidney
    Magno Goncalves, Marcus Vinicius
    Grzesiuk, Anderson Kuntz
    Nunes Machado, Suzana Costa
    da Cunha Matta, Andre Palma
    Mendes, Maria Fernanda
    Goncalves Jube Ribeiro, Taysa Alexandrino
    da Rocha, Cristiane Franklin
    Ruocco, Heloisa Helena
    Sato, Henry
    Simm, Renata Faria
    Tauil, Carlos Bernardo
    Ferreira Vasconcelos, Claudia Cristina
    Ferreira Vieira, Vera Lucia
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (04) : 541 - 546
  • [22] Fingolimod withdrawalRebound syndrome after the withdrawal of fingolimod: case report
    Reactions Weekly, 2019, 1750 (1) : 126 - 126
  • [23] Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
    Hoepner, Robert
    Havla, Joachim
    Eienbroeker, Christian
    Tackenberg, Bjoern
    Hellwig, Kerstin
    Meinl, Ingrid
    Hohlfeld, Reinhard
    Gold, Ralf
    Kuempfel, Tania
    Kleiter, Ingo
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (13) : 1714 - 1720
  • [24] Exacerbation of multiple sclerosis after withdrawal and restart of treatment with natalizumab
    Beume, L.
    Dersch, R.
    Fuhrer, H.
    Guggenmoos, S.
    Stich, O.
    Rauer, S.
    Niesen, W.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 464 - 464
  • [25] COST MINIMIZATION ANALYSIS OF FINGOLIMOD COMPARED TO NATALIZUMAB IN PATIENTS WITH RELAPSE REMITTING MULTIPLE SCLEROSIS IN THE NETHERLANDS
    Verheggen, B.
    Treur, M.
    Groot, M.
    VALUE IN HEALTH, 2011, 14 (07) : A323 - A323
  • [26] Severe multiple sclerosis relapse on fingolimod
    Nealon, N.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S230 - S231
  • [27] Fingolimod withdrawalRebound of multiple sclerosis: case report
    Reactions Weekly, 2014, 1523 (1) : 96 - 96
  • [28] Natalizumab withdrawalRebound multiple sclerosis: case report
    Reactions Weekly, 2017, 1646 (1) : 242 - 242
  • [29] Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
    Bigaut, K.
    Kremer, L.
    Fabacher, T.
    Ahle, G.
    Goudot, M.
    Fleury, M.
    Gaultier, C.
    Courtois, S.
    Collongues, N.
    de Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 577 - 578
  • [30] Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal
    Serafini, Barbara
    Scorsi, Eleonora
    Rosicarelli, Barbara
    Rigau, Valerie
    Thouvenot, Eric
    Aloisi, Francesca
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 307 : 14 - 17
12345